Related references
Note: Only part of the references are listed.A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone
Kuei C. Lee et al.
NEOPLASIA (2007)
Diffusion magnetic resonance imaging: A biomarker for treatment response in oncology
Daniel A. Hamstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
An Imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone
Kuei C. Lee et al.
CANCER RESEARCH (2007)
Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging
Paul A. Armitage et al.
MAGNETIC RESONANCE IMAGING (2007)
Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy
Kuei C. Lee et al.
CLINICAL CANCER RESEARCH (2007)
Imaging response in malignant glioma, RTOG 90-06
Robert A. Lustig et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy
Kutei C. Lee et al.
CLINICAL CANCER RESEARCH (2007)
Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance
Victor D. Schepkin et al.
NMR IN BIOMEDICINE (2006)
Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results
Yoshiko Hayashida et al.
EUROPEAN RADIOLOGY (2006)
Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer
Martin D. Pickles et al.
MAGNETIC RESONANCE IMAGING (2006)
Dynamic Imaging of emerging resistance during cancer therapy
Kuei C. Lee et al.
CANCER RESEARCH (2006)
Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors
VD Schepkin et al.
MAGNETIC RESONANCE IMAGING (2006)
The functional diffusion map: An imaging biomarker for the early prediction of cancer treatment outcome
Bradford A. Moffat et al.
NEOPLASIA (2006)
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma
IR Kamel et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit
KC Lee et al.
GENE THERAPY (2006)
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma
DA Hamstra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Functional diffusion map: A noninvasive MR1 biomarker for early stratification of clinical brain tumor response
BA Moffat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice
Y Roth et al.
RADIOLOGY (2004)
Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging
C Kremser et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2003)
Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging
Y Mardor et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Diffusion-weighted magnetic resonance imaging for. monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study
PA Hein et al.
EUROPEAN JOURNAL OF RADIOLOGY (2003)
Imaging response to chemotherapy with RMP-7 and carboplatin in malignant glioma: size matters but speed does not
R Grant et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors
TL Chenevert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy
LD Stegman et al.
GENE THERAPY (2000)
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
AM Chinnaiyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
